GUJARAT INJECT (KERALA) Q2 FY27 ; STANDALONE NET PROFIT UP 974.52% AT ₹0.73 CR (YOY), DOWN 42.05% (QOQ)

REVENUE UP 269.21% AT ₹5.82 CR (YOY), DOWN 53.27% (QOQ) EBITDA UP 3079.14% AT ₹1.04 CR (YOY), DOWN 38.59% (QOQ) MARGINS AT 17.81% VS 2.07% (YOY), 13.55% (QOQ)

GUJARAT INJECT (KERALA) LTD.

← Back to feed